Objectives: To investigate volumetric changes, in vivo biocompatibility, and systemic migration from eight commercial materials in paste/paste, powder/liquid, and pre-mixed forms.
Material and Methods: After characterisation, tubes were implanted in Wistar rats’ alveolar bone and subcutaneous tissues. Micro-CT evaluated volumetric changes pre/post 30 days of implantation. Histological and immunohistochemistry analyses assessed biocompatibility. Kidney samples underwent spectrometry (ICP-MS) for tantalum, tungsten and zirconium. Statistical analysis determined normality and significance (p < 0.05).
Results: Characterisation revealed calcium, silicon, and radiopacifiers in the materials. Volumetric changes showed greater alteration in subcutaneous tissues than alveolar bone; BioRoot RCS and MTApex (powder/liquid) were most stable. Histological analysis indicated intense inflammation for AH Plus Jet, moderate for others; IL-10 was marked positively for all materials. Unexpectedly, AH Plus Jet had an 18-fold higher tungsten and a 37-fold higher zirconium mass fraction in kidneys versus controls, while tantalum showed lower accumulation patterns.
Conclusion: Root canal filling materials’ responses varied by implantation site and form, demonstrating acceptable biocompatibility. Tantalum and zirconium oxide radiopacifiers appear systemically safe; tungsten-based radiopacifiers are unsuitable due to metal accumulation risks.
Clinical Relevance: This study highlights the need for further in vivo studies on endodontic sealers’ chemical, biological, and physical behaviors and their systemic migration.